Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study ( ÍCARA).

Conclusions. One-year AIT treatment significantly increases QoL in patients with AR. Moreover, high patients' satisfaction values were reported, together with an adequate safety profile. PMID: 31287263 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31287263?dopt=Abstract

Source: European Annals of Allergy and Clinical Immunology - July 11, 2019 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research